Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress

Kidney International

Volumn 55, Issue 4, 1999, Pages 1450-1461

  Galle, Jan ^a,b,c,d   Schneider, Reinhard ^a,b,c,d   Heinloth, Alexandra ^a,b,c,d   Wanner, Christoph ^a,b,c,d   Galle, Peter R ^a,b,c,d   Conzelmann, Ernst ^a,b,c,d   Dimmeler, Stephanie ^a,b,c,d   Heermeier, Kathrin ^a,b,c,d  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; Atherogenesis; Endothelium; Lipoprotein; Lysophosphatidylcholine; Superoxide radical

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; CATALASE; DIETHYLDITHIOCARBAMIC ACID; DNA FRAGMENT; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL TISSUE; AORTA; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DEATH; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

EID: 0032930114     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00351.x     Document Type: Article

References (56)

1. MAGH AB, FROHLICH JJ, INNIS SM, STEINBRECHER UP: Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 43:1243-1250, 1993
2. HOLVOET P, COLLEN D: Thrombosis and atherosclerosis. Curr Opin Lipidol 8:320-328, 1997
3. Ross R: Cell biology of atherosclerosis. Annu Rev Physiol 57:791-804, 1995
4. BERLINER JA, NAVAB M, FOGELMAN AM, FRANK JS, DEMER LL, EDWARDS PA, WATSON AD, LUSIS AJ: Atherosclerosis. Basic mechanisms: Oxidation, inflammation, and genetics. Circulation 91:2488-2496, 1995
5. DAHLÉN GH: Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108:111-126, 1994
6. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809, 1993
7. OHARA Y, PETERSON TE, HARRISON DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551, 1993
8. MÜGGE A, BRANDES RP, BÖGER RH, DWENGER A, BODE-BÖGER S, KIENKE S, FRÖLICH JC, LICHTLEN PR: Vascular release of super-oxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovase Pharmacol 24:994-998, 1994
9. BERLINER JA, HEINECKE JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20:707-727, 1996
10. HARRISON DG, OHARA Y: Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: Implications for impaired vasomotion. Am J Cardiol 75:75B-81B, 1995
11. KATUSIC ZS: Superoxide union and endothelial regulation of arterial tone. Free Radic Biol Med 20:443-448, 1996
12. DREXLER H, ZEIHER AM: Endothelial function in human coronary arteries in vivo: Focus on hypercholesterolemia. Hypertension 18:90-99, 1991
13. ZEIHER AM, DREXLER H, SAURBIER B, JUST H: Endothelium-mediated coronary blood flow modulation in humans: Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92:652-662, 1993
14. GALLE J, BENGEN J, SCHOLLMEYER P, WANNER C: Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a): Role of oxygen-derived radicals. Circulation 92:1582-1589, 1995
15. YLÄ-HERTTUALA S, PALINSKI W, ROSENFELD ME, PARTHASARATHY S, CAREW TE, BUTLER S, WITZUM JL, STEINBERG D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095, 1989
16. RATH M, NIENDORF A, REBLIN T, DIETEL M, KREBBER HJ, BEISTEGEL U: Detection and quantification of lipoprotein(A) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 9:579-592, 1989
17. LEE HS, KIM YS: Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int 54:848-856, 1998
18. LI PF, DIETZ R, VON HARSDORF R: Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett 404:249-252, 1997
19. JACOBSON MD: Reactive oxygen species and programmed cell death. Trends Biochem Sci 21:83-86, 1996
20. SUGIYAMA H, KASHIHAKA N, MAKINO H, YAMASAKI Y, OTA Z: Reactive oxygen species induce apoptosis in cultured human mesangial cells. J Am Soc Nephrol 7:2357-2363, 1996
21. WOOD KA, YOULE RJ: Apoptosis and free radicals. Ann NY Acad Sci 738:40-47, 1994
22. HAENDELER J, ZEIHER AM, DIMMELER S: Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol 317:407-411, 1996
23. CAPLAN BA, SCHWARTZ CJ: Increased endothelial cell turnover in areas of in vivo Evans blue uptake in the pig aorta. Atherosclerosis 17:401-417, 1973
24. BJÖRKERUD S, BJÖRKERUD B: Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 149:367-380, 1996
25. KOCKX MM, DE MEYER GRY, MUHRING J, BULI H, BULTINCK J, HERMAN AG: Distribution of cell replication and apoptosis in atheroselerotic plaques of cholesterol-fed rabbits. Atherosclerosis 120:115-124, 1996
26. HAN DKM, HAUDENSCHILD CC, HONG MK, TINKLE BT, LEON MB, LIAU G: Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 147:267-277, 1995
27. DIMMELER S, HAENDELER J, GALLE J, ZEIHER AM: Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: A mechanistic clue to the "response to injury" hypothesis. Circulation 93:1700-1763, 1997
28. COHEN GM: Caspases: The executioners of apoptosis. Biochem J 326:1-16, 1997
29. DIXIT VM: Role of ice-proteases in apoptosis. Adv Exp Med Biol 406:113-117, 1996
30. OHARA Y, PETERSON TE, ZHENG B, KUO JF, HARRISON DG: Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Anterioscler Thromb 14:1007-1013, 1994
31. FREEMAN JE, KUO WY, DRENGER B, BARNETT TN, LEVINE MA, FLAVAHAN NA: Analysis of lysophosphatidylcholine-induced endothelial dysfunction. J Cardiovasc Pharmacol 28:345-352, 1996
32. - and renin release in juxtaglomerular cells. Kidney Int 51:253-260, 1997
33. LUWRY OH, ROSEBROUGH NJ, FARR AL, RANDALI RJ: Protein measurement with phenol reagent. J Biol Chem 193:265-275, 1951
34. JANERO DR: Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515-540, 1990
35. BUSSE R, POHL U, KELLNER C, KLEMM U: Endothelial cells are involved in the vasodilatory response to hypoxia. Pflügers Arch 397:78-80, 1983
36. VAN GELDER BF, SLATER EC: The extinction coefficient of cytochrome c. Biochim Biophys Acta 58:593-595, 1962
37. GALLE J, SCHNEIDER R, WINNER B, LEHMANN-BODEM C, SCHINZEL R, MÜNCH G, CONZELMANN E, WANNER C: Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: Role of enhanced oxidative stress. Atherosclerosis 138:65-77, 1998
38. FOLCH J, LEES M, SLOANE-STANLEY GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
39. HALLIWELL B: The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23(Suppl 1):118-126, 1993
40. ESTERBAUER H, GEBICKI J, PUHI H, JÜRGENS G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Fret Radic Biol Med 13:341-390, 1992
41. MACLELLAN WR, SCHNEIDER MD: Death by design: Programmed cell death in cardiovascular biology and disease. Circ Res 81:137-144, 1997
42. ROSENFELD ME, PALINSKI W, YLÄ-HERTTUALA S, BUTLER S, WITZ-TUM JL: Distribution of oxidation specific lipid-protein adducts and apolipoprotein-B in atherosclerotic lesions of varying severity from whhl rabbits. Arteriosclerosis 10:336-349, 1990
43. ROSS R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993
44. RANGASWAMY S, PENN MS, SAIDEL GM, CHISOLM GM: Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ Res 80:37-44, 1997
45. BJÖRKERUD B, BJÖRKERUD S: Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus-apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol 16:416-424, 1996
46. NISHIO E, WATANABE Y: Oxysterols induced apotosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Biochem Biophys Res Commun 226:928-934, 1996
47. ESCARGUEIL-BLANC I, MEILHAC O, PIERAGGI MT, ARNAL JF, SALVAYRE R, NÈGRE-SALVAYRE A: Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway: Prevention by aurintricarboxylic acid. Arterioscler Thromb Vase Biol 17:331-339, 1997
48. SUC I, ESCARGUEIL-BLANC I, TROLY M, SALVAYRE R, NÈGRE-SALVAYRE A: HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler Thromb Vasc Biol 17:2158-2166, 1997
49. BUTTKE TM, SANDSTROM PA: Oxidative stress as a mediator of apoptosis. Immunol Today 15:7-10, 1994
50. HANSEN PR, KHARAZMI AK, JAUHIAINEN M, EHNHOLM C: Induction of free radical generation in human monocytes by lipoprotein(a). Eur J Clin Invest 24:497-499, 1994
51. KUSHI LH, FOLSOM AR, PRINEAS RJ, MINK PJ, WU Y, BOSTICK RM: Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334:1156-1162, 1996
52. LIOCHEV SI, FRIDOVICH I: Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production. Arch Biochem Biophys 337:115-120, 1997
53. LI Y, ZHU H, KUPPUSAMY P, ROUBAUD V, ZWEIER JL, TRUSH MA: Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem 273:2015-2023, 1998
54. PARTHASARATHY S, STEINBRECHER U, BARNETT J, WITZTUM JL, STEINBERG D: Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82:3000-3004, 1985
55. YOKOYAMA M, HIRATA K, MIYAKE R, AKITA H, ISHIKAWA Y, FUKUZAKI H: Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun 168:301-308, 1990
56. ESTERBAUER H, JÜRGENS G, QUEHENBERGER O, KOLLER E: Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 28:495-509, 1987